IMCC (IM Cannabis) Change In Receivables: $9.03 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IMCC IM Cannabis Corp IMCC
37 GF Score
Price $0.14
GF Value $1.26
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is IM Cannabis Change In Receivables?

IM Cannabis IMCC +2.42% 37 Change In Receivables is $9.03 Mil as of Mar. 2026. GuruFocus rates IMCC with a GF Score™ of 37/100 and a GF Value™ of $1.26 (Possible Value Trap). The stock has 8 warning signs investors should review.

IM Cannabis's change in receivables for the quarter that ended in Mar. 2026 was $2.67 Mil. It means IM Cannabis's Accounts Receivable declined by $2.67 Mil from Dec. 2025 to Mar. 2026 .

IM Cannabis's change in receivables for the fiscal year that ended in Dec. 2025 was $2.94 Mil. It means IM Cannabis's Accounts Receivable declined by $2.94 Mil from Dec. 2024 to Dec. 2025 .

IM Cannabis's Accounts Receivable for the quarter that ended in Mar. 2026 was $5.22 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. IM Cannabis's Days Sales Outstanding for the three months ended in Mar. 2026 was 75.35.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. IM Cannabis's liquidation value for the three months ended in Mar. 2026 was $-15.63 Mil.

IM Cannabis  (NAS:IMCC) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

IM Cannabis's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=5.224/6.326*91
=75.35

2. In Ben Graham's calculation of liquidation value, IM Cannabis's accounts receivable are only considered to be worth 75% of book value:

IM Cannabis's liquidation value for the quarter that ended in Mar. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.732-21.009+0.75 * 5.224+0.5 * 1.458
=-15.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IM Cannabis Change In Receivables Related Terms

IM Cannabis Change In Receivables Historical Data

* Premium members only.

The historical data trend for IM Cannabis's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IM Cannabis Change In Receivables Chart

IM Cannabis Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.50 4.46 1.73 -4.41 2.94

IM Cannabis Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.24 4.60 -0.59 2.35 2.67
IMCC
37GF Score
IM Cannabis Corp IMCC
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IM Cannabis Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $9.03 Mil mean?
IM Cannabis (IMCC) has a Change In Receivables of $9.03 Mil as of Mar. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for IM Cannabis and its competitors.
Is IM Cannabis' Change In Receivables too high?
IM Cannabis' current Change In Receivables is $9.03 Mil. Overall, IM Cannabis has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does IM Cannabis' Change In Receivables compare to BSPK and NPHC?
IM Cannabis' Change In Receivables of $9.03 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Drug Manufacturers company?
A good Change In Receivables depends on the Drug Manufacturers industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for IM Cannabis and its competitors. IM Cannabis's current Change In Receivables is $9.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IM Cannabis stock overvalued right now?
Based on GuruFocus' analysis, IM Cannabis (IMCC) is currently considered Possible Value Trap. The stock's GF Value™ is $1.26, compared to a current price of $0.14 — trading 88.9% below its estimated fair value. The current Change In Receivables is $9.03 Mil. IM Cannabis' overall GF Score™ is 37/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For IM Cannabis (IMCC), the current Change In Receivables is $9.03 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IM Cannabis (IMCC) Overvalued in 2026?

Based on GuruFocus' analysis, IM Cannabis stock appears to be undervalued. The current stock price of $0.14 is trading 88.9% below its estimated GF Value™ of $1.26. GuruFocus considers IM Cannabis to be Possible Value Trap.

Key valuation signals for IMCC:

  • Change In Receivables: $9.03 Mil
  • GF Value™: $1.26 vs. price of $0.14 (88.9% below fair value)
  • GF Score™: 37/100 with 8 warning signs

No single metric tells the full story. See the IMCC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IM Cannabis Business Description

Address Central District, Kibbutz Glil Yam, ISR, 4690500
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
37GF Score

Get the complete analysis for IMCC

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.14
Price
$1.26
GF Value